Evidence map›Paper›PMID 28716644›Full record

ArticleChest2017

MUC5AC and a Glycosylated Variant of MUC5B Alter Mucin Composition in Children With Acute Asthma.

Kathryn G Welsh, Karine Rousseau, Gemma Fisher, Luke R Bonser, Peter Bradding, Chris E Brightling, David J Thornton, Erol A Gaillard

Open access · hybridAbstract read
In one paragraph

Article in Chest, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it, 95 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Requirement for Fucosyltransferase 2 in Allergic Airway Hyperreactivity and Mucus Obstruction.American journal of respiratory cell and molecular biology · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Emerging cell and molecular targets for treating mucus hypersecretion in asthma.Allergology international : official journal of the Japanese Society of Allergology · 2024
    Review
  17. Article
  18. Article
  19. The epithelium takes the stage in asthma and inflammatory bowel diseases.Frontiers in cell and developmental biology · 2024
    Review
  20. BPIFB1 loss alters airway mucus properties and diminishes mucociliary clearance.American journal of physiology. Lung cellular and molecular physiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 1 country.

Kathryn G WelshInstitute for Lung Health, National Institute for Health Research Leicester Biomedical Research Centre, and Department of Infection Immunity and Inflammation, University of Leicester, and University Hospitals Leicester, Children's Hospital, Leicester, England.
Karine RousseauWellcome Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, England.
Gemma FisherInstitute for Lung Health, National Institute for Health Research Leicester Biomedical Research Centre, and Department of Infection Immunity and Inflammation, University of Leicester, and University Hospitals Leicester, Children's Hospital, Leicester, England.
Luke R BonserWellcome Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, England.
Peter BraddingInstitute for Lung Health, National Institute for Health Research Leicester Respiratory Biomedical Research Unit, and Department of Infection Immunity and Inflammation, University of Leicester, and University Hospitals Leicester, Glenfield Hospital, Leicester, England.
Chris E BrightlingInstitute for Lung Health, National Institute for Health Research Leicester Respiratory Biomedical Research Unit, and Department of Infection Immunity and Inflammation, University of Leicester, and University Hospitals Leicester, Glenfield Hospital, Leicester, England.
David J ThorntonWellcome Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, England.
Erol A GaillardInstitute for Lung Health, National Institute for Health Research Leicester Biomedical Research Centre, and Department of Infection Immunity and Inflammation, University of Leicester, and University Hospitals Leicester, Children's Hospital, Leicester, England. Electronic address: eag15@le.ac.uk.
NIHR Leicester Biomedical Research Centre · GBGlenfield Hospital · GBManchester Academic Health Science Centre · GBNational Institute for Health Research · GBUniversity of Leicester · GBUniversity of Manchester · GBWellcome Centre for Cell-Matrix Research · GB

Funding

Medical Research Council G1000450Wellcome TrustWellcome Trust 088785/Z/09/Z
6 · The paper itself

Abstract

backgroundDiffuse airway mucus obstruction is an important feature of severe and fatal asthma. MUC5AC and MUC5B are the principal gel-forming mucins found in airway mucus. The mucin composition of airway mucus likely affects its functional properties.

methodsWe quantified the principal airway mucins MUC5AC and MUC5B in the sputum of age-matched children with acute and stable asthma and healthy control subjects by using Western blotting.

resultsSputum samples from 38 children (13 with acute asthma, 15 with stable asthma, 10 control subjects) were obtained. Sputum MUC5AC concentrations were 7.6 μg/mL in control subjects, 22.4 μg/mL in those with stable asthma (P = .17), and 44.7 μg/mL in those with acute asthma (P < .05). MUC5B concentrations showed less variation, with 238.5, 208.4 and 165.9 μg/mL in control subjects, those with stable asthma, and those with acute asthma, respectively. The greater MUC5AC concentration in those with acute asthma resulted in a significantly altered MUC5B:MUC5AC ratio between control subjects and those with acute asthma (P < .05). Significant differences in MUC5B glycoforms were present between the groups, with the low-charge-only glycoform being found uniquely in those with acute asthma.

conclusionsIncreased MUC5AC and the presence of a low-charge-only MUC5B glycoform significantly altered mucin composition in children with acute asthma. These changes may be important contributory factors to the airway mucus obstruction observed during acute asthma.

Indexed as

Acute DiseaseAdolescentAsthmaBiomarkersBlotting, WesternChildChild, PreschoolFemaleHumansMaleMucin 5ACMucin-5BMucinsMucusRespiratory MucosaSputumBiomarkersMUC5AC protein, humanMUC5B protein, humanMucin 5ACMucin-5BMucinsairway obstructionexacerbationmucuspediatricsputum plug

Identifiers

PMID28716644
PMCPMC5624091
OpenAlexW2736132057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.